Lohr K N, Eleazer K, Mauskopf J
Research Triangle Institute, Research Triangle Park, NC 27709, USA.
Health Policy. 1998 Oct;46(1):1-19. doi: 10.1016/s0168-8510(98)00044-x.
Evidence-based medicine and clinical practice guidelines have become increasingly salient to the international health care community in the 1990s. Key issues in health policy in this period can be categorised as costs and access to care, quality of and satisfaction with care, accountability for value in health care, and public health and education. This paper presents a brief overview of evidence-based medicine and clinical practice guidelines and describes how they are likely to influence health policy. Evidence-based medicine focuses on the use of the best available clinical (efficacy) evidence to inform decisions about patient care; guidelines are statements systematically developed from efficacy and effectiveness research and clinical consensus for practitioners and patients to use in making decisions about appropriate care under different clinical circumstances. Both fields have developed methods for evaluating and synthesising available evidence about the outcomes of alternative health care interventions. They have clear implications for health policy analysts: greater reliance should be placed on scientific evidence, policy decisions should be derived systematically, and health care decisionmaking must allow for the active participation of health care providers, policy makers, and patients or their advocates. The methods and information generated from evidence-based guidelines efforts are critical inputs into health policy analysis and decision-making.
20世纪90年代,循证医学和临床实践指南在国际卫生保健领域变得越来越重要。这一时期卫生政策的关键问题可分为医疗成本与可及性、医疗质量与满意度、医疗保健价值的问责制以及公共卫生与教育。本文简要概述了循证医学和临床实践指南,并描述了它们可能如何影响卫生政策。循证医学侧重于利用最佳可得的临床(疗效)证据为患者护理决策提供依据;指南是根据疗效和有效性研究以及临床共识系统制定的声明,供从业者和患者在不同临床情况下做出适当护理决策时使用。这两个领域都开发了评估和综合关于替代卫生保健干预措施结果的现有证据的方法。它们对卫生政策分析人员具有明确的启示:应更多地依赖科学证据,政策决策应系统得出,医疗保健决策必须允许医疗保健提供者、政策制定者以及患者或其倡导者积极参与。循证指南工作产生的方法和信息是卫生政策分析和决策的关键输入。